Treatment restrictions due to coronavirus (COVID-19)

As part of our longstanding relationship, we are proud to be dedicating our resources to the NHS at this important time. As a result many of our treatments are currently suspended and we are reviewing all planned procedures and consultations. We are making every effort to talk to impacted patients and apologise for any inconvenience this may cause.

NociScan launches in Europe at Spire Nottingham Hospital

10 December 2019

Rory Kelsey, Spire Nottingham Imaging Manager with Andreas and Peter from Nocimed. MRI scanner featured with advanced Nocimed technology.

Nocimed, a leader in the diagnosis of Degenerative Disc Disease (DDD) pain using a non-invasive test measuring the biomarkers associated with disc pain, has launched in Europe at Spire Nottingham Hospital.

Nocimed has been marketing its unique technology to healthcare clinicians focusing on spine surgery, radiology and pain management using images from existing MRI equipment to perform the scan. NociScan detects the presence of chemical biomarkers associated with disc pain and structural integrity of the annulus of the disc making diagnosis faster and less uncomfortable for the patient.

“The opportunity to be the first site in the UK for NociScan allows Spire Nottingham Hospital to expand its spinal diagnostic capabilities, and offer innovative services for the benefit of our Consultants and Patients”, said Ed Ireland, Director of Clinical Services at Spire Nottingham Hospital. “We welcome this new innovation.”

Any patients requiring more information on accessing this scan at Spire Nottingham can call our Private Treatment Advisors on 0115 937 7735 or email nottinghamhospprivatetreatment@spirehealthcare.com.

Event Booking Form

120477

Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

Enquire by phone
Enquire online